Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
Net Margin
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
Peer Comparison
| Country | Company | Market Cap |
Net Margin |
||
|---|---|---|---|---|---|
| ID |
|
Industri Jamu dan Farmasi Sido Muncul Tbk PT
IDX:SIDO
|
15.6T IDR |
Loading...
|
|
| US |
|
Kenvue Inc
NYSE:KVUE
|
34.6B USD |
Loading...
|
|
| BR |
|
Natura &Co Holding SA
OTC:NTCOY
|
7.7B USD |
Loading...
|
|
| KR |
A
|
APR Co Ltd
KRX:278470
|
10T KRW |
Loading...
|
|
| CN |
M
|
Mao Geping Cosmetics Co Ltd
HKEX:1318
|
44.1B HKD |
Loading...
|
|
| KY |
H
|
Herbalife Ltd
XMUN:HOO
|
4.7B EUR |
Loading...
|
|
| IL |
O
|
Oddity Tech Ltd
NASDAQ:ODD
|
1.7B USD |
Loading...
|
|
| KR |
d
|
d'Alba Global Co Ltd
KRX:483650
|
2.1T KRW |
Loading...
|
|
| CN |
|
Runben Biotechnology Co Ltd
SSE:603193
|
9.7B CNY |
Loading...
|
|
| CN |
D
|
Dencare Chongqing Oral Care Co Ltd
SZSE:001328
|
7.5B CNY |
Loading...
|
|
| IN |
H
|
Honasa Consumer Ltd
NSE:HONASA
|
94.5B INR |
Loading...
|
Market Distribution
| Min | -220 730.8% |
| 30th Percentile | 0% |
| Median | 3.7% |
| 70th Percentile | 9.8% |
| Max | 190 521.4% |
Other Profitability Ratios
Industri Jamu dan Farmasi Sido Muncul Tbk PT
Glance View
Industri Jamu dan Farmasi Sido Muncul Tbk PT, a name synonymous with traditional Indonesian herbal remedies, represents a blend of age-old wisdom and modern business acumen. Founded in 1940, the company originally started as a small herbal medicine business, peddling concoctions crafted from local plants and herbs. Over the decades, it transformed into a leading player in the Indonesian pharmaceutical industry through its commitment to nurturing folk medicine heritage and melding it with contemporary manufacturing processes. Today's Sido Muncul operates sophisticated production facilities that comply with stringent safety and quality standards, embodying the rich tradition of jamu – Indonesia’s indigenous elixir – while ensuring products meet the demands of modern efficacy and safety. The company earns its revenue from an extensive array of products, primarily categorized into herbal medicines, supplements, and health drinks. Notably, an innovative approach lies at the core of its earnings strategy: leveraging the health benefits of jamu to cater to an increasingly health-conscious population. With a prolific distribution network, Sido Muncul ensures its products reach both local and international markets, spanning across Asia, the Middle East, and beyond. Their diverse range of offerings, from energy-bolstering drinks to ailment-specific concoctions, reinforces its financial robustness, serving a wide clientele that values both health and tradition. The firm’s continuous investment in research and development helps it stay ahead in the competitive herbal market, steadily propelling its growth and fortifying its role as a custodian of Indonesian cultural heritage in the global arena.
See Also
Net Margin is calculated by dividing the Net Income by the Revenue.
The current Net Margin for Industri Jamu dan Farmasi Sido Muncul Tbk PT is 30.1%, which is above its 3-year median of 28.7%.
Over the last 3 years, Industri Jamu dan Farmasi Sido Muncul Tbk PT’s Net Margin has increased from 28.9% to 30.1%. During this period, it reached a low of 26.7% on Dec 31, 2023 and a high of 30.2% on Jun 30, 2025.